SCHEMBL7696969

SCHEMBL7696969

O=C(NCC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(OCc2ccc3ccccc3c2)cc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.56
GPR132 Q9UNW8 3/20 0.53
PTPN2 P17706 1/20 0.52
CDC25B P30305 1/20 0.52
ACE P12821 4/20 0.50
CTSL P07711 1/20 0.50
CTSB P07858 1/20 0.50
CTSS P25774 1/20 0.50
CTSK P43235 1/20 0.50
GAA P10253 1/20 0.50
RAB9A P51151 1/20 0.50
CA2 P00918 1/20 0.49
NPC1 O15118 1/20 0.49
MAPT P10636 1/20 0.49
PPARG P37231 1/20 0.48
SPHK2 Q9NRA0 1/20 0.48
MAOB P27338 1/20 0.48
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
ALOX5 P09917 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694848 0.92 PTPN1 (0.55) PTPN1GPR132PTPN2CDC25BACE
SCHEMBL7664997 0.87 PTPN1 (0.51) PTPN1PTPN2CDC25BCTSLCTSB
SCHEMBL7702953 0.87 PTPN1 (0.53) PTPN1GPR132PTPN2CDC25BACE
SCHEMBL7701695 0.86 CA2 (0.52) PTPN1GPR132PTPN2CDC25BACE
SCHEMBL7694676 0.83 CTSL (0.49) PTPN1PTPN2CDC25BACECTSL
SCHEMBL7789811 0.82 PIN1 (0.55) PTPN1GPR132PTPN2CDC25BNPC1
SCHEMBL7789810 0.82 PIN1 (0.55) PTPN1GPR132PTPN2CDC25BNPC1
SCHEMBL1123112 0.80 PTPN1 (0.64) PTPN1GPR132PTPN2CDC25BCA2
SCHEMBL7789862 0.79 CAPN1 (0.72) PTPN1GPR132PTPN2CDC25BRAB9A
SCHEMBL7789863 0.79 CAPN1 (0.72) PTPN1GPR132PTPN2CDC25BRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed